NDC 65862-925

Incassia

Norethindrone

Incassia is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Norethindrone.

Product ID65862-925_0caa1c4e-9536-49b0-a523-b6a6676434ba
NDC65862-925
Product TypeHuman Prescription Drug
Proprietary NameIncassia
Generic NameNorethindrone
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2016-09-23
Marketing CategoryANDA / ANDA
Application NumberANDA207304
Labeler NameAurobindo Pharma Limited
Substance NameNORETHINDRONE
Active Ingredient Strength0 mg/1
Pharm ClassesProgesterone Congeners [CS],Progestin [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 65862-925-28

1 BLISTER PACK in 1 CARTON (65862-925-28) > 1 TABLET in 1 BLISTER PACK
Marketing Start Date2016-09-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65862-925-87 [65862092587]

Incassia TABLET
Marketing CategoryANDA
Application NumberANDA207304
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-09-23

NDC 65862-925-92 [65862092592]

Incassia TABLET
Marketing CategoryANDA
Application NumberANDA207304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-23

NDC 65862-925-28 [65862092528]

Incassia TABLET
Marketing CategoryANDA
Application NumberANDA207304
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-09-23

NDC 65862-925-86 [65862092586]

Incassia TABLET
Marketing CategoryANDA
Application NumberANDA207304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-23

NDC 65862-925-85 [65862092585]

Incassia TABLET
Marketing CategoryANDA
Application NumberANDA207304
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2016-09-23

NDC 65862-925-88 [65862092588]

Incassia TABLET
Marketing CategoryANDA
Application NumberANDA207304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-09-23

Drug Details

Active Ingredients

IngredientStrength
NORETHINDRONE.35 mg/1

OpenFDA Data

SPL SET ID:0b87cef0-610c-469d-92ba-4007f4bc3878
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 2052064
  • 198042
  • 748961

    • Pharmacological Class

    • Progesterone Congeners [CS]
    • Progestin [EPC]

    NDC Crossover Matching brand name "Incassia" or generic name "Norethindrone"

    NDCBrand NameGeneric Name
    65862-925IncassiaIncassia
    51862-102CamilaNorethindrone
    51862-884CAMILANORETHINDRONE
    16714-440DEBLITANENorethindrone
    0555-0344ErrinNorethindrone
    51862-100ErrinNorethindrone
    51862-886ERRINNORETHINDRONE
    57297-877Jencyclanorethindrone
    52544-892JolivetteNORETHINDRONE
    50102-300LyleqNORETHINDRONE
    53002-1793LyleqNORETHINDRONE
    50102-100LYZAnorethindrone
    53002-1687LYZAnorethindrone
    52544-629Nora BENorethindrone
    0378-7272NorethindroneNorethindrone
    0378-7292NORETHINDRONEnorethindrone
    50090-2150NorethindroneNorethindrone
    50090-6161NORETHINDRONENORETHINDRONE
    57297-876NORETHINDRONENORETHINDRONE
    63187-748NorethindroneNorethindrone
    42291-650Norethindrone AcetateNorethindrone
    50268-602Norethindrone AcetateNorethindrone
    50090-3235Norlydanorethindrone
    51660-127NORLYROCnorethindrone
    50458-194Ortho MicronorNORETHINDRONE
    16714-441SHAROBELNorethindrone
    50102-200TulanaNORETHINDRONE
    53002-2687TulanaNORETHINDRONE

    Trademark Results [Incassia]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    INCASSIA
    INCASSIA
    87190473 5740199 Live/Registered
    Aurobindo Pharma Ltd.
    2016-10-01
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.